11-55343666-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005274.1(OR4A16):c.466G>A(p.Val156Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000187 in 1,613,806 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005274.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR4A16 | NM_001005274.1 | c.466G>A | p.Val156Ile | missense_variant | 1/1 | ENST00000314721.5 | NP_001005274.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR4A16 | ENST00000314721.5 | c.466G>A | p.Val156Ile | missense_variant | 1/1 | 6 | NM_001005274.1 | ENSP00000325128.2 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152032Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000283 AC: 71AN: 250864Hom.: 1 AF XY: 0.000266 AC XY: 36AN XY: 135570
GnomAD4 exome AF: 0.000183 AC: 267AN: 1461656Hom.: 1 Cov.: 33 AF XY: 0.000173 AC XY: 126AN XY: 727126
GnomAD4 genome AF: 0.000223 AC: 34AN: 152150Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 22, 2021 | The c.466G>A (p.V156I) alteration is located in exon 1 (coding exon 1) of the OR4A16 gene. This alteration results from a G to A substitution at nucleotide position 466, causing the valine (V) at amino acid position 156 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at